Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Valls

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Cirugia Espanola|December 17, 2008
[Bile duct cysts in adults: surgical procedure]Joan Altet, Antonio Rafecas, Joan Fabregat, et al.
European Journal of Radiology|August 29, 2018
Radiological assessment of local resectability status in patients with pancreatic cancer: Interreader agreement and reader performance in two different classification systemsLouiza Loizou, Carlos Valls Duran, Elisabet Axelsson, et al.
Cirugia Espanola|October 30, 2010
[Surgical treatment of pancreatic adenocarcinoma using cephalic duodenopancreatectomy (Part 2). Long term follow up after 204 cases]Juan Fabregat, Juli Busquets, Núria Peláez, et al.
Pancreas|January 30, 2013
Factors influencing mortality in patients undergoing surgery for acute pancreatitis: importance of peripancreatic tissue and fluid infectionJuli Busquets, Juan Fabregat, Nuria Pelaez, et al.
Hepatology (Baltimore, Md.)|March 29, 2022
Reliability of extracellular contrast versus gadoxetic acid in assessing small liver lesions using liver imaging reporting and data system v.2018 and European association for the study of the liver criteriaJordi Rimola, Víctor Sapena, Giuseppe Brancatelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancerGraeme J Poston, René Adam, Steven Alberts, et al.
Cancer Chemotherapy and Pharmacology|September 19, 2018
Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial)Joan Maurel, Santiago Sánchez-Cabús, Berta Laquente, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Cirugia Espanola|December 17, 2008
[Bile duct cysts in adults: surgical procedure]Joan Altet, Antonio Rafecas, Joan Fabregat, et al.
European Journal of Radiology|August 29, 2018
Radiological assessment of local resectability status in patients with pancreatic cancer: Interreader agreement and reader performance in two different classification systemsLouiza Loizou, Carlos Valls Duran, Elisabet Axelsson, et al.
Cirugia Espanola|October 30, 2010
[Surgical treatment of pancreatic adenocarcinoma using cephalic duodenopancreatectomy (Part 2). Long term follow up after 204 cases]Juan Fabregat, Juli Busquets, Núria Peláez, et al.
Pancreas|January 30, 2013
Factors influencing mortality in patients undergoing surgery for acute pancreatitis: importance of peripancreatic tissue and fluid infectionJuli Busquets, Juan Fabregat, Nuria Pelaez, et al.
Hepatology (Baltimore, Md.)|March 29, 2022
Reliability of extracellular contrast versus gadoxetic acid in assessing small liver lesions using liver imaging reporting and data system v.2018 and European association for the study of the liver criteriaJordi Rimola, Víctor Sapena, Giuseppe Brancatelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancerGraeme J Poston, René Adam, Steven Alberts, et al.
Cancer Chemotherapy and Pharmacology|September 19, 2018
Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial)Joan Maurel, Santiago Sánchez-Cabús, Berta Laquente, et al.
Pageof 4